Skip to main content
PMC home page
Biophysical Journal logoLink to Biophysical Journal
. 2001 Nov;81(5):2979–2991. doi: 10.1016/S0006-3495(01)75938-3

Comparison of the membrane association of two antimicrobial peptides, magainin 2 and indolicidin.

H Zhao 1, J P Mattila 1, J M Holopainen 1, P K Kinnunen 1
PMCID: PMC1301762  PMID: 11606308

Abstract

Interactions of two antimicrobial peptides, magainin 2 and indolicidin, with three different model biomembranes, namely, monolayers, large unilamellar vesicles (LUVs), and giant liposomes, were studied. Insertion of both peptides into lipid monolayers was progressively enhanced when the content of an acidic phospholipid, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG) in a film of 1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (SOPC) was increased. Indolicidin and magainin 2 penetrated also into lipid monolayers containing cholesterol (mole fraction, X = 0.1). Membrane association of magainin 2 attenuated lipid lateral diffusion in POPG-containing LUVs as revealed by the decrease in the excimer/monomer fluorescence ratio I(e)/I(m) for the pyrene fatty-acid-containing phospholipid derivative 1-palmitoyl-2-[10-(pyren-1-yl) decanoyl]-sn-glycero-3-phospho-rac-glycerol (PPDPG). Likewise, an increase in steady-state fluorescence anisotropy of the membrane-incorporated diphenylhexatriene (DPH) was observed, revealing magainin 2 to increase acyl chain order and induce segregation of acidic phospholipids. Similar effects were observed for indolicidin. The topological effects of magainin 2 and indolicidin on phospholipid membranes were investigated using optical microscopy of giant vesicles. Magainin 2 had essentially no influence on either SOPC or SOPC:cholesterol (X = 0.1) giant liposomes. However, effective vesiculation was observed when acidic phospholipid (X(PG) = 0.1) was included in the giant vesicles. Indolicidin caused only a minor shrinkage of giant SOPC vesicles whereas the formation of endocytotic vesicles was observed when the giant liposome contained POPG (X(PG) = 0.1). Interestingly, for indolicidin, vesiculation was also observed for giant vesicles composed of SOPC/cholesterol (X(chol) = 0.1). Possible mechanisms of membrane transformation induced by these two peptides are discussed.

Full Text

The Full Text of this article is available as a PDF (304.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad I., Perkins W. R., Lupan D. M., Selsted M. E., Janoff A. S. Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity. Biochim Biophys Acta. 1995 Jul 26;1237(2):109–114. doi: 10.1016/0005-2736(95)00087-j. [DOI] [PubMed] [Google Scholar]
  2. Aley S. B., Zimmerman M., Hetsko M., Selsted M. E., Gillin F. D. Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect Immun. 1994 Dec;62(12):5397–5403. doi: 10.1128/iai.62.12.5397-5403.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Altamirano MS, Borsarelli CD, Cosa JJ, Previtali CM. Influence of Polarity and Viscosity of the Micellar Interface on the Fluorescence Quenching of Pyrenic Compounds by Indole Derivatives in AOT Reverse Micelles Solutions. J Colloid Interface Sci. 1998 Sep 15;205(2):390–396. doi: 10.1006/jcis.1998.5650. [DOI] [PubMed] [Google Scholar]
  4. Angelova M. I., Hristova N., Tsoneva I. DNA-induced endocytosis upon local microinjection to giant unilamellar cationic vesicles. Eur Biophys J. 1999;28(2):142–150. doi: 10.1007/s002490050193. [DOI] [PubMed] [Google Scholar]
  5. Angelova M. I., Tsoneva I. Interactions of DNA with giant liposomes. Chem Phys Lipids. 1999 Aug;101(1):123–137. doi: 10.1016/s0009-3084(99)00060-2. [DOI] [PubMed] [Google Scholar]
  6. Baker M. A., Maloy W. L., Zasloff M., Jacob L. S. Anticancer efficacy of Magainin2 and analogue peptides. Cancer Res. 1993 Jul 1;53(13):3052–3057. [PubMed] [Google Scholar]
  7. Bechinger B. Structure and functions of channel-forming peptides: magainins, cecropins, melittin and alamethicin. J Membr Biol. 1997 Apr 1;156(3):197–211. doi: 10.1007/s002329900201. [DOI] [PubMed] [Google Scholar]
  8. Bechinger B. The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy. Biochim Biophys Acta. 1999 Dec 15;1462(1-2):157–183. doi: 10.1016/s0005-2736(99)00205-9. [DOI] [PubMed] [Google Scholar]
  9. Bechinger B., Zasloff M., Opella S. J. Structure and orientation of the antibiotic peptide magainin in membranes by solid-state nuclear magnetic resonance spectroscopy. Protein Sci. 1993 Dec;2(12):2077–2084. doi: 10.1002/pro.5560021208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brockman H. Lipid monolayers: why use half a membrane to characterize protein-membrane interactions? Curr Opin Struct Biol. 1999 Aug;9(4):438–443. doi: 10.1016/S0959-440X(99)80061-X. [DOI] [PubMed] [Google Scholar]
  11. Cruciani R. A., Barker J. L., Zasloff M., Chen H. C., Colamonici O. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3792–3796. doi: 10.1073/pnas.88.9.3792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Demel R. A., Geurts van Kessel W. S., Zwaal R. F., Roelofsen B., van Deenen L. L. Relation between various phospholipase actions on human red cell membranes and the interfacial phospholipid pressure in monolayers. Biochim Biophys Acta. 1975 Sep 16;406(1):97–107. doi: 10.1016/0005-2736(75)90045-0. [DOI] [PubMed] [Google Scholar]
  13. Dougherty D. A. Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp. Science. 1996 Jan 12;271(5246):163–168. doi: 10.1126/science.271.5246.163. [DOI] [PubMed] [Google Scholar]
  14. Falla T. J., Karunaratne D. N., Hancock R. E. Mode of action of the antimicrobial peptide indolicidin. J Biol Chem. 1996 Aug 9;271(32):19298–19303. doi: 10.1074/jbc.271.32.19298. [DOI] [PubMed] [Google Scholar]
  15. Hirsh D. J., Hammer J., Maloy W. L., Blazyk J., Schaefer J. Secondary structure and location of a magainin analogue in synthetic phospholipid bilayers. Biochemistry. 1996 Oct 1;35(39):12733–12741. doi: 10.1021/bi961468a. [DOI] [PubMed] [Google Scholar]
  16. Holopainen J. M., Angelova M. I., Kinnunen P. K. Vectorial budding of vesicles by asymmetrical enzymatic formation of ceramide in giant liposomes. Biophys J. 2000 Feb;78(2):830–838. doi: 10.1016/S0006-3495(00)76640-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Holopainen J. M., Lehtonen J. Y., Kinnunen P. K. Evidence for the extended phospholipid conformation in membrane fusion and hemifusion. Biophys J. 1999 Apr;76(4):2111–2120. doi: 10.1016/S0006-3495(99)77367-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jackson M., Mantsch H. H., Spencer J. H. Conformation of magainin-2 and related peptides in aqueous solution and membrane environments probed by Fourier transform infrared spectroscopy. Biochemistry. 1992 Aug 18;31(32):7289–7293. doi: 10.1021/bi00147a012. [DOI] [PubMed] [Google Scholar]
  19. Ladokhin A. S., Selsted M. E., White S. H. Bilayer interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids. Biophys J. 1997 Feb;72(2 Pt 1):794–805. doi: 10.1016/s0006-3495(97)78713-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ladokhin A. S., Selsted M. E., White S. H. CD spectra of indolicidin antimicrobial peptides suggest turns, not polyproline helix. Biochemistry. 1999 Sep 21;38(38):12313–12319. doi: 10.1021/bi9907936. [DOI] [PubMed] [Google Scholar]
  21. Lange Y., Dolde J., Steck T. L. The rate of transmembrane movement of cholesterol in the human erythrocyte. J Biol Chem. 1981 Jun 10;256(11):5321–5323. [PubMed] [Google Scholar]
  22. Ludtke S. J., He K., Heller W. T., Harroun T. A., Yang L., Huang H. W. Membrane pores induced by magainin. Biochemistry. 1996 Oct 29;35(43):13723–13728. doi: 10.1021/bi9620621. [DOI] [PubMed] [Google Scholar]
  23. Ludtke S. J., He K., Wu Y., Huang H. W. Cooperative membrane insertion of magainin correlated with its cytolytic activity. Biochim Biophys Acta. 1994 Feb 23;1190(1):181–184. doi: 10.1016/0005-2736(94)90050-7. [DOI] [PubMed] [Google Scholar]
  24. Ludtke S., He K., Huang H. Membrane thinning caused by magainin 2. Biochemistry. 1995 Dec 26;34(51):16764–16769. doi: 10.1021/bi00051a026. [DOI] [PubMed] [Google Scholar]
  25. Matsuzaki K., Harada M., Funakoshi S., Fujii N., Miyajima K. Physicochemical determinants for the interactions of magainins 1 and 2 with acidic lipid bilayers. Biochim Biophys Acta. 1991 Mar 18;1063(1):162–170. doi: 10.1016/0005-2736(91)90366-g. [DOI] [PubMed] [Google Scholar]
  26. Matsuzaki K., Harada M., Handa T., Funakoshi S., Fujii N., Yajima H., Miyajima K. Magainin 1-induced leakage of entrapped calcein out of negatively-charged lipid vesicles. Biochim Biophys Acta. 1989 May 19;981(1):130–134. doi: 10.1016/0005-2736(89)90090-4. [DOI] [PubMed] [Google Scholar]
  27. Matsuzaki K. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim Biophys Acta. 1998 Nov 10;1376(3):391–400. doi: 10.1016/s0304-4157(98)00014-8. [DOI] [PubMed] [Google Scholar]
  28. Matsuzaki K., Murase O., Fujii N., Miyajima K. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry. 1996 Sep 3;35(35):11361–11368. doi: 10.1021/bi960016v. [DOI] [PubMed] [Google Scholar]
  29. Matsuzaki K., Murase O., Fujii N., Miyajima K. Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore. Biochemistry. 1995 May 16;34(19):6521–6526. doi: 10.1021/bi00019a033. [DOI] [PubMed] [Google Scholar]
  30. Matsuzaki K., Murase O., Miyajima K. Kinetics of pore formation by an antimicrobial peptide, magainin 2, in phospholipid bilayers. Biochemistry. 1995 Oct 3;34(39):12553–12559. doi: 10.1021/bi00039a009. [DOI] [PubMed] [Google Scholar]
  31. Matsuzaki K., Murase O., Tokuda H., Funakoshi S., Fujii N., Miyajima K. Orientational and aggregational states of magainin 2 in phospholipid bilayers. Biochemistry. 1994 Mar 22;33(11):3342–3349. doi: 10.1021/bi00177a027. [DOI] [PubMed] [Google Scholar]
  32. Matsuzaki K., Nakayama M., Fukui M., Otaka A., Funakoshi S., Fujii N., Bessho K., Miyajima K. Role of disulfide linkages in tachyplesin-lipid interactions. Biochemistry. 1993 Nov 2;32(43):11704–11710. doi: 10.1021/bi00094a029. [DOI] [PubMed] [Google Scholar]
  33. Matsuzaki K., Sugishita K., Fujii N., Miyajima K. Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. Biochemistry. 1995 Mar 14;34(10):3423–3429. doi: 10.1021/bi00010a034. [DOI] [PubMed] [Google Scholar]
  34. Matsuzaki K., Sugishita K., Harada M., Fujii N., Miyajima K. Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim Biophys Acta. 1997 Jul 5;1327(1):119–130. doi: 10.1016/s0005-2736(97)00051-5. [DOI] [PubMed] [Google Scholar]
  35. Matsuzaki K., Sugishita K., Ishibe N., Ueha M., Nakata S., Miyajima K., Epand R. M. Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry. 1998 Aug 25;37(34):11856–11863. doi: 10.1021/bi980539y. [DOI] [PubMed] [Google Scholar]
  36. Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta. 1999 Dec 15;1462(1-2):1–10. doi: 10.1016/s0005-2736(99)00197-2. [DOI] [PubMed] [Google Scholar]
  37. Op den Kamp J. A. Lipid asymmetry in membranes. Annu Rev Biochem. 1979;48:47–71. doi: 10.1146/annurev.bi.48.070179.000403. [DOI] [PubMed] [Google Scholar]
  38. Oren Z., Shai Y. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers. 1998;47(6):451–463. doi: 10.1002/(SICI)1097-0282(1998)47:6<451::AID-BIP4>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  39. Riquelme G., Lopez E., Garcia-Segura L. M., Ferragut J. A., Gonzalez-Ros J. M. Giant liposomes: a model system in which to obtain patch-clamp recordings of ionic channels. Biochemistry. 1990 Dec 25;29(51):11215–11222. doi: 10.1021/bi00503a009. [DOI] [PubMed] [Google Scholar]
  40. Robinson W. E., Jr, McDougall B., Tran D., Selsted M. E. Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophils. J Leukoc Biol. 1998 Jan;63(1):94–100. doi: 10.1002/jlb.63.1.94. [DOI] [PubMed] [Google Scholar]
  41. Saberwal G., Nagaraj R. Cell-lytic and antibacterial peptides that act by perturbing the barrier function of membranes: facets of their conformational features, structure-function correlations and membrane-perturbing abilities. Biochim Biophys Acta. 1994 Jun 29;1197(2):109–131. doi: 10.1016/0304-4157(94)90002-7. [DOI] [PubMed] [Google Scholar]
  42. Sansom M. S. The biophysics of peptide models of ion channels. Prog Biophys Mol Biol. 1991;55(3):139–235. doi: 10.1016/0079-6107(91)90004-c. [DOI] [PubMed] [Google Scholar]
  43. Schluesener H. J., Radermacher S., Melms A., Jung S. Leukocytic antimicrobial peptides kill autoimmune T cells. J Neuroimmunol. 1993 Sep;47(2):199–202. doi: 10.1016/0165-5728(93)90030-3. [DOI] [PubMed] [Google Scholar]
  44. Schnorf M., Potrykus I., Neuhaus G. Microinjection technique: routine system for characterization of microcapillaries by bubble pressure measurement. Exp Cell Res. 1994 Feb;210(2):260–267. doi: 10.1006/excr.1994.1038. [DOI] [PubMed] [Google Scholar]
  45. Selsted M. E., Novotny M. J., Morris W. L., Tang Y. Q., Smith W., Cullor J. S. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J Biol Chem. 1992 Mar 5;267(7):4292–4295. [PubMed] [Google Scholar]
  46. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta. 1999 Dec 15;1462(1-2):55–70. doi: 10.1016/s0005-2736(99)00200-x. [DOI] [PubMed] [Google Scholar]
  47. Sitaram N., Nagaraj R. Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity. Biochim Biophys Acta. 1999 Dec 15;1462(1-2):29–54. doi: 10.1016/s0005-2736(99)00199-6. [DOI] [PubMed] [Google Scholar]
  48. Subbalakshmi C., Krishnakumari V., Nagaraj R., Sitaram N. Requirements for antibacterial and hemolytic activities in the bovine neutrophil derived 13-residue peptide indolicidin. FEBS Lett. 1996 Oct 14;395(1):48–52. doi: 10.1016/0014-5793(96)00996-9. [DOI] [PubMed] [Google Scholar]
  49. Tytler E. M., Anantharamaiah G. M., Walker D. E., Mishra V. K., Palgunachari M. N., Segrest J. P. Molecular basis for prokaryotic specificity of magainin-induced lysis. Biochemistry. 1995 Apr 4;34(13):4393–4401. doi: 10.1021/bi00013a031. [DOI] [PubMed] [Google Scholar]
  50. Verger R., Pattus F. Spreading of membranes at the air/water interface. Chem Phys Lipids. 1976 Jul;16(4):285–291. doi: 10.1016/0009-3084(76)90023-2. [DOI] [PubMed] [Google Scholar]
  51. Wieprecht T., Dathe M., Beyermann M., Krause E., Maloy W. L., MacDonald D. L., Bienert M. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Biochemistry. 1997 May 20;36(20):6124–6132. doi: 10.1021/bi9619987. [DOI] [PubMed] [Google Scholar]
  52. Williams R. W., Starman R., Taylor K. M., Gable K., Beeler T., Zasloff M., Covell D. Raman spectroscopy of synthetic antimicrobial frog peptides magainin 2a and PGLa. Biochemistry. 1990 May 8;29(18):4490–4496. doi: 10.1021/bi00470a031. [DOI] [PubMed] [Google Scholar]
  53. Wimley W. C., White S. H. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat Struct Biol. 1996 Oct;3(10):842–848. doi: 10.1038/nsb1096-842. [DOI] [PubMed] [Google Scholar]
  54. Wu M., Maier E., Benz R., Hancock R. E. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry. 1999 Jun 1;38(22):7235–7242. doi: 10.1021/bi9826299. [DOI] [PubMed] [Google Scholar]
  55. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5449–5453. doi: 10.1073/pnas.84.15.5449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Zasloff M., Martin B., Chen H. C. Antimicrobial activity of synthetic magainin peptides and several analogues. Proc Natl Acad Sci U S A. 1988 Feb;85(3):910–913. doi: 10.1073/pnas.85.3.910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. van Ginkel G., van Langen H., Levine Y. K. The membrane fluidity concept revisited by polarized fluorescence spectroscopy on different model membranes containing unsaturated lipids and sterols. Biochimie. 1989 Jan;71(1):23–32. doi: 10.1016/0300-9084(89)90127-2. [DOI] [PubMed] [Google Scholar]

Articles from Biophysical Journal are provided here courtesy of The Biophysical Society

RESOURCES